Suppr超能文献

相似文献

1
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines.
J Allergy Clin Immunol. 2012 Apr;129(4):974-82.e13. doi: 10.1016/j.jaci.2012.01.059. Epub 2012 Mar 3.
2
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma.
J Allergy Clin Immunol. 2013 Sep;132(3):676-685.e13. doi: 10.1016/j.jaci.2013.04.012. Epub 2013 Jun 4.
3
Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function.
J Allergy Clin Immunol. 2017 Jun;139(6):1819-1829.e11. doi: 10.1016/j.jaci.2016.09.022. Epub 2016 Oct 13.
4
Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma.
Allergy. 2013 Mar;68(3):402-6. doi: 10.1111/all.12101. Epub 2013 Jan 25.
5
Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests.
Am J Respir Crit Care Med. 2006 Dec 15;174(12):1286-91. doi: 10.1164/rccm.200603-352OC. Epub 2006 Sep 14.
8
Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms.
J Allergy Clin Immunol. 2015 Aug;136(2):323-33. doi: 10.1016/j.jaci.2015.01.014. Epub 2015 Mar 5.
9
Lung Lavage Granulocyte Patterns and Clinical Phenotypes in Children with Severe, Therapy-Resistant Asthma.
J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1803-1812.e10. doi: 10.1016/j.jaip.2018.12.027. Epub 2019 Jan 14.

引用本文的文献

3
IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential.
Front Immunol. 2025 Jan 24;16:1533335. doi: 10.3389/fimmu.2025.1533335. eCollection 2025.
5
Evaluating Severe Therapy-Resistant Asthma in Children: Diagnostic and Therapeutic Strategies.
Medicina (Kaunas). 2024 Nov 2;60(11):1799. doi: 10.3390/medicina60111799.
7
Pediatric asthma comorbidities: Global impact and unmet needs.
World Allergy Organ J. 2024 May 22;17(5):100909. doi: 10.1016/j.waojou.2024.100909. eCollection 2024 May.
8
A murine model of peanut-allergic asthma.
Front Allergy. 2024 Apr 25;5:1378877. doi: 10.3389/falgy.2024.1378877. eCollection 2024.
10
The role of IL10 and IL17 gene polymorphisms in treatment response in children and adolescents with severe asthma.
J Bras Pneumol. 2024 Jan 15;49(6):e20230092. doi: 10.36416/1806-3756/e20230092. eCollection 2024.

本文引用的文献

1
Mechanisms controlling Th17 cytokine expression and host defense.
J Leukoc Biol. 2011 Aug;90(2):263-70. doi: 10.1189/jlb.0211099. Epub 2011 Apr 12.
2
Cytokine/anti-cytokine therapy - novel treatments for asthma?
Br J Pharmacol. 2011 May;163(1):81-95. doi: 10.1111/j.1476-5381.2011.01219.x.
3
IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist.
J Allergy Clin Immunol. 2010 Oct;126(4):875-8. doi: 10.1016/j.jaci.2010.08.001.
4
Management of severe asthma in children.
Lancet. 2010 Sep 4;376(9743):814-25. doi: 10.1016/S0140-6736(10)61054-9.
5
Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.
Ann Intern Med. 2010 Feb 16;152(4):232-7. doi: 10.7326/0003-4819-152-4-201002160-00008.
6
The importance of nurse-led home visits in the assessment of children with problematic asthma.
Arch Dis Child. 2009 Oct;94(10):780-4. doi: 10.1136/adc.2008.152140. Epub 2009 Jun 21.
7
Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma.
Eur Respir J. 2009 Nov;34(5):1052-9. doi: 10.1183/09031936.00186508. Epub 2009 Jun 18.
8
Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction.
J Allergy Clin Immunol. 2009 Jul;124(1):45-51.e1-4. doi: 10.1016/j.jaci.2009.03.049. Epub 2009 May 29.
9
Mepolizumab for difficult-to-control asthma with persistent sputum eosinophilia.
Expert Opin Investig Drugs. 2009 Jun;18(6):869-71. doi: 10.1517/13543780902922678.
10
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验